Identity
- Security key
- 23413
- Ticker
- VNRX
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2007-04-25
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- VNRX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $8,052,845.06
- Shares outstanding (class)
- 12,044,339
- Shares outstanding (weighted)
- 12,044,339
- SIC
- 2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Employees
- 75
- Location
- HENDERSON, NV
- Homepage
- https://www.volition.com
- Description
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
Market cap and share counts drift.